annual EBIT:
-$104.55M-$21.02M(-25.17%)Summary
- As of today (August 1, 2025), ELVN annual earnings before interest & taxes is -$104.55 million, with the most recent change of -$21.02 million (-25.17%) on December 31, 2024.
- During the last 3 years, ELVN annual EBIT has fallen by -$79.79 million (-322.24%).
- ELVN annual EBIT is now -1022.06% below its all-time high of -$9.32 million, reached on December 1, 2020.
Performance
ELVN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$31.69M-$4.80M(-17.84%)Summary
- As of today (August 1, 2025), ELVN quarterly earnings before interest & taxes is -$31.69 million, with the most recent change of -$4.80 million (-17.84%) on March 31, 2025.
- Over the past year, ELVN quarterly EBIT has dropped by -$5.71 million (-21.96%).
- ELVN quarterly EBIT is now -277.52% below its all-time high of -$8.39 million, reached on December 1, 2021.
Performance
ELVN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$110.26M-$5.71M(-5.46%)Summary
- As of today (August 1, 2025), ELVN TTM earnings before interest & taxes is -$110.26 million, with the most recent change of -$5.71 million (-5.46%) on March 31, 2025.
- Over the past year, ELVN TTM EBIT has dropped by -$17.16 million (-18.43%).
- ELVN TTM EBIT is now -1213.40% below its all-time high of -$8.39 million, reached on December 1, 2021.
Performance
ELVN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELVN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.2% | -22.0% | -18.4% |
| 3 y3 years | -322.2% | -265.2% | -545.8% |
| 5 y5 years | -1022.1% | -277.5% | -1213.4% |
ELVN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -322.2% | at low | -251.5% | at low | -322.6% | at low |
| 5 y | 5-year | -1022.1% | at low | -277.5% | at low | -1213.4% | at low |
| alltime | all time | -1022.1% | at low | -277.5% | at low | -1213.4% | at low |
ELVN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$31.69M(+17.8%) | -$110.26M(+5.5%) |
| Dec 2024 | -$104.55M(+25.2%) | -$26.90M(-0.6%) | -$104.55M(+4.2%) |
| Sep 2024 | - | -$27.07M(+10.0%) | -$100.39M(+2.9%) |
| Jun 2024 | - | -$24.60M(-5.3%) | -$97.57M(+4.8%) |
| Mar 2024 | - | -$25.99M(+14.3%) | -$93.10M(+11.5%) |
| Dec 2023 | -$83.53M | -$22.73M(-6.3%) | -$83.53M(+17.7%) |
| Sep 2023 | - | -$24.25M(+20.4%) | -$70.96M(+23.1%) |
| Jun 2023 | - | -$20.13M(+22.6%) | -$57.65M(+23.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$16.42M(+61.5%) | -$46.53M(+20.0%) |
| Dec 2022 | -$38.79M(+56.7%) | -$10.16M(-7.1%) | -$38.79M(+4.8%) |
| Sep 2022 | - | -$10.93M(+21.3%) | -$37.02M(+41.9%) |
| Jun 2022 | - | -$9.02M(+3.9%) | -$26.09M(+52.8%) |
| Mar 2022 | - | -$8.68M(+3.4%) | -$17.07M(+103.4%) |
| Dec 2021 | -$24.76M(+165.7%) | - | - |
| Dec 2021 | - | -$8.39M | -$8.39M |
| Dec 2020 | -$9.32M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual EBIT year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Enliven Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM EBIT year-on-year change?
What is Enliven Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of ELVN is -$104.55M
What is the all time high annual EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$9.32M
What is Enliven Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, ELVN annual earnings before interest & taxes has changed by -$21.02M (-25.17%)
What is Enliven Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ELVN is -$31.69M
What is the all time high quarterly EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$8.39M
What is Enliven Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, ELVN quarterly earnings before interest & taxes has changed by -$5.71M (-21.96%)
What is Enliven Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ELVN is -$110.26M
What is the all time high TTM EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$8.39M
What is Enliven Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, ELVN TTM earnings before interest & taxes has changed by -$17.16M (-18.43%)